Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan

A. Takaki (Tokyo, Japan), A. Aono (Tokyo, Japan), K. Chikamatsu (Tokyo, Japan), Y. Igarashi (Tokyo, Japan), Y. Shimomura (Tokyo, Japan), Y. Murase (Tokyo, Japan), H. Yoshida (Osaka, Japan), . Tamura (Osaka, Japan), T. Nagai (Osaka, Japan), Y. Morishige (Tokyo, Japan), H. Yamada (Tokyo, Japan), S. Mitarai (Tokyo, Japan)

Source: International Congress 2019 – Drug-resistant tuberculosis
Session: Drug-resistant tuberculosis
Session type: Oral Presentation
Number: 2137
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Takaki (Tokyo, Japan), A. Aono (Tokyo, Japan), K. Chikamatsu (Tokyo, Japan), Y. Igarashi (Tokyo, Japan), Y. Shimomura (Tokyo, Japan), Y. Murase (Tokyo, Japan), H. Yoshida (Osaka, Japan), . Tamura (Osaka, Japan), T. Nagai (Osaka, Japan), Y. Morishige (Tokyo, Japan), H. Yamada (Tokyo, Japan), S. Mitarai (Tokyo, Japan). Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan. 2137

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: